Fiona Caldicott
Fiona Caldicott is a prominent figure in the field of psychiatry and healthcare in the United Kingdom. She has made significant contributions to the development of medical ethics and patient privacy standards, particularly in the context of health information technology.
Early Life and Education[edit | edit source]
Fiona Caldicott was born in England. She pursued her education in the field of medicine, specializing in psychiatry. She completed her medical degree from the University of Oxford, one of the most prestigious universities in the world.
Career[edit | edit source]
Caldicott has held numerous high-profile positions throughout her career. She served as the President of the Royal College of Psychiatrists from 1993 to 1996. She was also the Principal of Somerville College, Oxford from 1996 to 2010.
In 1997, Caldicott was appointed to lead a review of patient-identifiable information, which came to be known as the Caldicott Report. The report established six principles, known as the Caldicott Principles, to ensure that patient information is handled with respect and confidentiality. These principles have since been adopted widely across the UK's National Health Service (NHS).
Caldicott Guardians[edit | edit source]
Following the Caldicott Report, the role of Caldicott Guardian was established within the NHS. Caldicott Guardians are senior staff in NHS organizations who are responsible for protecting the confidentiality of patient information and enabling appropriate information sharing.
Honours and Awards[edit | edit source]
In recognition of her contributions to psychiatry and healthcare, Caldicott has received several honours and awards. She was made a Dame Commander of the Order of the British Empire (DBE) in 1996. In 2012, she was awarded the Honorary Fellowship of the Royal College of General Practitioners.
See Also[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD